Streetbeat News

PCLOF

PharmaCielo Ltd.

Industry

All Other Miscellaneous Crop Farming

Open

0.06

Mkt cap

7.5M

Volume

500

High

0.06

P/E Ratio

-0.88

52-wk high

0.22

Low

0.05

Div yield

N/A

52-wk low

0.05

PharmaCielo Ltd. announced its intention to extend the expiry date of its warrants. The company is a leading cultivator and producer of cannabis extracts in Colombia.

Portfolio Pulse from

November 05, 2024 | 5:45 pm

Colombia's new decree allows the sale of dry cannabis flower locally, benefiting companies and patients. While it seems to protect small producers, it actually favors MIPYMES based on income, allowing many companies to qualify. Regulatory hurdles like sanitary authorization may delay implementation.

Portfolio Pulse from Javier Hasse

October 24, 2024 | 5:29 pm

The Czech Republic could miss out on $242 million annually by not regulating its marijuana market, according to a study. The study suggests that a comprehensive model, including self-cultivation, cannabis clubs, and a commercial market, would yield the highest social benefits. Companies like Curaleaf, PharmaCielo, Tilray, and Canopy Growth are already expanding their presence in the Czech market, potentially benefiting from future policy changes.

Portfolio Pulse from Jelena Martinovic

September 16, 2024 | 2:00 pm

PharmaCielo Ltd. (OTC:PCLOF) reported a 390% YoY revenue increase to CA$783,680 in Q2 2024, driven by cannabis derivative sales. Net loss narrowed to CA$2.6 million from CA$3.6 million in Q2 2023. The company issued 5.98 million shares for debt settlement and reduced operating expenses. Despite positive financial trends, PCLOF shares were down 4.78% to $0.0857.

Portfolio Pulse from Patricio Liddle

August 16, 2024 | 2:47 pm

The article discusses the potential for cannabis legalization in Venezuela amid political turmoil and election fraud allegations. It highlights the successes of Colombia's cannabis industry and mentions companies like Clever Leaves Holdings Inc, Khiron Life Sciences Corp, and PharmaCielo Ltd as examples of successful cannabis businesses in Colombia.

Portfolio Pulse from Patricio Liddle

July 31, 2024 | 1:02 pm

The Czech Republic is considering a fully legal commercial adult-use cannabis market under its 'Cannabis Management Act,' which includes provisions for personal cultivation, licensing, and a regulated market. Companies like Curaleaf Holdings, PharmaCielo, Tilray Brands, and Canopy Growth are already positioning themselves in anticipation of these regulatory changes.

Portfolio Pulse from Jelena Martinovic

July 15, 2024 | 2:20 pm

PharmaCielo Ltd. (TSXV:PCLO, OTC:PCLOF) reported a 31% year-over-year reduction in net loss for Q1 2024, driven by significant cost-cutting measures. The company also announced the revocation of a cease trade order by the Ontario Securities Commission and a downgrade in its TSX Venture Exchange tier classification.

Portfolio Pulse from Jelena Martinovic

July 05, 2024 | 3:02 pm

PharmaCielo Ltd. (OTCQX:PCLOF) announced its intention to acquire Siam Ventures Corporation, aiming to expand its cannabis operations into Thailand amidst regulatory changes. The deal involves issuing PharmaCielo shares worth CA$3 million ($2.2 million) to Siam Ventures' shareholders. This acquisition is seen as a strategic move to access large Asian markets as they open to cannabinoids. Concurrently, PharmaCielo is undertaking a non-brokered private placement of units to raise CA$2 million, potentially increasing to CA$3 million, to support its expansion and operational needs.

Portfolio Pulse from Jelena Martinovic

April 10, 2024 | 2:49 pm

Clever Leaves Holdings Inc. partners with Paradise Seeds to develop cannabis cultivars in Colombia, aiming to expand its global footprint. Avicanna Inc. receives approval for Trunerox to treat epilepsy in Colombia, marking a significant milestone. However, Colombian Congress shelved a bill for regulating adult cannabis use, reflecting legislative divisions. This regulatory landscape impacts companies like Clever Leaves, PharmaCielo Ltd, and Khiron Life Sciences Corp, as they navigate the evolving market.

Portfolio Pulse from Nicolás Jose Rodriguez

February 14, 2024 | 4:21 pm

Benuvia Operations LLC and PharmaCielo Ltd (OTCQX:PCLOF) (TSXV:PCLO) have announced a strategic partnership to manufacture CGMP pharmaceutical-grade Active Pharmaceutical Ingredients (APIs) for the global market. PharmaCielo will cultivate cannabis and hemp in Colombia, while Benuvia will produce the final product in Texas. The partnership aims to offer Seed-to-Pharma products globally, ensuring quality and compliance. PharmaCielo also plans to issue common shares to satisfy interest payments on debentures. PCLOF's shares were trading at $0.107 at the time of the announcement.

Portfolio Pulse from Patricio Liddle

January 04, 2024 | 5:11 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.